QIN-SARCOMA | QIN-SARCOMA
DOI: 10.7937/K9/TCIA.2016.fXL9sESs | Data Citation Required | 73 Views | 1 Citations | Image Collection
| Location | Species | Subjects | Data Types | Cancer Types | Size | Status | Updated |
|---|---|---|---|---|---|---|---|
| Breast, Calf, Chest, Elbow, Knee, Leg, Shoulder, and Thigh | Human | 15 | MR | Sarcomas | Limited, Complete | 2014/09/04 |
Summary
This collection of soft-tissue sarcoma dynamic contrast-enhanced (DCE) MRI data contains images from a longitudinal study to assess soft-tissue sarcoma response to preoperative chemoradiation treatment. Images were acquired at three time points: prior to the start of treatment (Visit 1, V1), after the first cycle of chemotherapy (Visit 2, V2), and after ~ 8 more weeks of chemoradiation (prior to surgery) (Visit 3, V3). Not every patient was able to complete all three MRI studies. The value of this collection is to provide clinical imaging data for the development and validation of quantitative imaging methods for assessment of soft-tissue sarcoma response to preoperative treatment. Initial findings of this study have been published and the data is provided by Oregon Health & Science University, PI Dr. Wei Huang. The MRI data consist of DCE-MRI images only, which were acquired using a Siemens 3T TIM Trio system with the body coil as the transmitter and a body matrix phased array (combined with a spine matrix phased array) coil as the receiver. Following scout and axial T2-weighted MRI, a RF-spoiled gradient-echo sequence was used to acquire sagittal DCE-MRI images covering the entire tumor, with 100 flip angle, TE/TR = 1.5/6.0 ms, 24-26 cm field of view (FOV), and 5 mm slice thickness with 1 mm gap. A parallel imaging acceleration factor of 2 was used for DCE-MRI, resulting in 7-16 s temporal resolutions depending on tumor size. The total DCE acquisition time was approximately 10 min with gadolinium contrast agent (Prohance®) IV injection (0.1 mmol/kg at 2 mL/s) carried out following acquisition of five baseline image volumes, followed by a 20-mL saline flush.
Data Access
Once you have a TCIA account, please email to help@cancerimagingarchive.net to request access to these data.
Version 1: Updated 2014/09/04
| Title | Data Type | Format | Access Points | Subjects | License | |||
|---|---|---|---|---|---|---|---|---|
| Images | MR | DICOM | Download requires NBIA Data Retriever |
15 | 38 | 2,168 | 46,614 | TCIA Limited (contact Support) |
Citations & Data Usage Policy
Data Citation Required: Users must abide by the TCIA Data Usage Policy and Restrictions. Attribution must include the following citation, including the Digital Object Identifier:
Data Citation |
|
|
Huang, W., Ryan, C., Beckett, B., Tudorica, A., Mansoor, A., Afzal, A., Holtorf, M., & Aston, T. (2016). QIN-SARCOMA [Data set]. The Cancer Imaging Archive. https://doi.org/10.7937/K9/TCIA.2016.fXL9sESs |
Acknowledgement |
|
|
Please be sure to acknowledge the award that supported collection and sharing of these data (U01 CA154602, PI: Wei Huang) if you use the data set. |
Related Publications
Publications by the Dataset Authors
The authors recommended the following as the best source of additional information about this dataset:
Publication Citation |
|
|
Meyer, J. M., Perlewitz, K. S., Hayden, J. B., Doung, Y.-C., Hung, A. Y., Vetto, J. T., Pommier, R. F., Mansoor, A., Beckett, B. R., Tudorica, A., Mori, M., Holtorf, M. L., Afzal, A., Woodward, W. J., Rodler, E. T., Jones, R. L., Huang, W., & Ryan, C. W. (2013). Phase I Trial of Preoperative Chemoradiation plus Sorafenib for High-Risk Extremity Soft Tissue Sarcomas with Dynamic Contrast-Enhanced MRI Correlates. In Clinical Cancer Research (Vol. 19, Issue 24, pp. 6902–6911). American Association for Cancer Research (AACR). https://doi.org/10.1158/1078-0432.ccr-13-1594 PMCID: PMC3869565 |
No other publications were recommended by dataset authors.
Research Community Publications
TCIA maintains a list of publications that leveraged this dataset. If you have a manuscript you’d like to add please contact TCIA’s Helpdesk.